Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth

CD44 and EpCAM play crucial roles in intraperitoneal ovarian cancer development. In this study, we developed an RNA-based bispecific CD44-EpCAM aptamer that is capable of blocking CD44 and EpCAM simultaneously by fusing single CD44 and EpCAM aptamers with a double stranded RNA adaptor. With the aid...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jingying, Zhao, Shuhua, Yu, Xiaolin, Huang, Shuang, Liu, Hong Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399600/
https://www.ncbi.nlm.nih.gov/pubmed/28435472
http://dx.doi.org/10.7150/thno.17826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399600/
https://www.ncbi.nlm.nih.gov/pubmed/28435472
http://dx.doi.org/10.7150/thno.17826

Ejemplares similares